CAS RN: 305343-00-4
4-(2,4-Dichlorophenyl)-1,4-dihydro-[1,3,5]triazino[1,2-a]benzimidazol-2-amine
Product Availability
Choose a grade to view its available package options.
3 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251115 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250522 |
1g |
In stock |
Shanghai | Inquiry |
| Batchno.20250922 |
250mg |
In stock |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: >97%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 305343-00-4
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
2
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
| 1g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
305343-00-4 / 4-(2,4-dichlorophenyl)-1,4-dihydro-[1,3,5]triazino[1,2-a]benzimidazol-2-amine
Standard CAS: 305343-00-4
Multi CAS: No
Basic Information
CAS
305343-00-4
Multi CAS
No
Molecular Formula
C15H11CL2N5
Molecular Weight
332.200000
Exact Mass
331.039151
InChI
InChI=1S/C15H11Cl2N5/c16-8-5-6-9(10(17)7-8)13-20-14(18)21-15-19-11-3-1-2-4-12(11)22(13)15/h1-7,13H,(H3,18,19,20,21)
InChIKey
NFLCLMQFIWHNOP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
22
Aromatic heavy atom count
15
Fraction Csp3
0.07
Rotatable bonds
1
H-bond acceptors
5
H-bond donors
2
Molar refractivity
89.58
TPSA
68.23
LogP / Solubility
WLOGP
3.63
MLOGP
3.21
XLogP3
3.2
Consensus LogP
3.35
Log S (ESOL)
-4.63
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.9
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.95
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.17
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3.5